EUROPE – Are Revisions of the Orphan Drug Regulation and Adoption of a Regulation on “Unmet Medical Needs” on the Horizon

Published date11 September 2020
Subject MatterFDA,European Commission,EU,Proposed Regulation,Funding,Medical Reimbursement,Fast Track Process,Orphan Drugs,European Medicines Agency (EMA)
AuthorChristina Markus,Geneviève Michaux,Cassandra Rasmussen
Law FirmKing & Spalding

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT